Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sana Biotechnology, Inc.

1.76
-0.0100-0.56%
Post-market: 1.75-0.0099-0.56%18:43 EDT
Volume:1.69M
Turnover:2.95M
Market Cap:396.04M
PE:-1.52
High:1.82
Open:1.75
Low:1.68
Close:1.77
Loading ...
Sep 13, 2021

Major Issues Report

8-K - Current report
Sep 03, 2021

Major Issues Report

8-K - Current report
Aug 04, 2021

Major Issues Report

8-K - Current report
Aug 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 14, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Major Issues Report

8-K - Current report
Feb 08, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 03, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 02, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 28, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 28, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 20, 2021

Correspondence

CORRESP [Cover] - Correspondence